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Although the biomarker carcinoembryonic antigen (CEA) is expressed in colorectal tumors, the utility of an
anti-CEA-functionalized image medium is powerful for in vivo positioning of colorectal tumors. With a risk of
superparamagnetic iron oxide nanoparticles (SPIONPs) that is lower for animals than other material carriers,
anti-CEA-functionalized SPIONPs were synthesized in this study for labeling colorectal tumors by conducting
different preoperatively and intraoperatively in vivo examinations. In magnetic resonance imaging (MRI), the image
variation of colorectal tumors reached the maximum at approximately 24 h. However, because MRI requires a
nonmetal environment, it was limited to preoperative imaging. With the potentiality of in vivo screening and
intraoperative positioning during surgery, the scanning superconducting-quantum-interference-device
biosusceptometry (SSB) was adopted, showing the favorable agreement of time-varied intensity with MRI.
Furthermore, biological methodologies of different tissue staining methods and inductively coupled plasma (ICP)
yielded consistent results, proving that the obtained in vivo results occurred because of targeted anti-CEA
SPIONPs. This indicates that developed anti-CEA SPIONPs owe the utilities as an image medium of these in vivo
methodologies.
Keywords: Carcinoembryonic antigen; Magnetic nanoparticles; Scanning superconducting-quantum-interference-
device biosusceptometry; Magnetic resonance imagingBackground
Colorectal tumors, which are caused by uncontrolled cell
growth in the colon or rectum [1], have constituted the
third most commonly diagnosed cancer in the world, es-
pecially in developed countries [2]. In screening methods,
a stool occult blood test is usually performed when the pa-
tient has experienced symptoms such as unusual bowel
habits. When the result is positive, flexible sigmoidoscopy,
barium enema, or colonoscopy is further applied. Because
of discomfort and risks, such as the colonic perforation
that can occur in these invasive methods, noninvasive
methods [3], such as computed tomography (CT), posi-
tron emission tomography (PET), and magnetic resonance
imaging (MRI), are alternatively used to image not only* Correspondence: jjchieh@ntnu.edu.tw; phyfv001@ntnu.edu.tw
3Institute of Electro-optical Science and Technology, National Taiwan Normal
University, Taipei 116, Taiwan
Full list of author information is available at the end of the article
© 2013 Huang et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is pthe primary colorectal tumor but also metastatic tumors
in other organs.
Two approaches can enhance the sensitivity and spe-
cificity of these medical imaging procedures [3]. The
first approach is the multimodality of structural im-
aging and functional imaging, such as the CT/PET and
MRI/PET. The second is based on image contrast
media using bioprobes. Here, the image contrast media
are the radioactive materials for CT and PET and the
superparamagnetic materials for MRI. It is well known
that these radioactive media and methodologies entail
a biological risk and that the clinically popular gadolin-
ium medium of MRI superparamagnetic materials
induces the side effect of kidney disease [4]. Because
iron oxide materials have a low risk of toxicity [5],
superparamagnetic iron oxide nanoparticles (SPIONPs)
coated with bioprobes have been developed for highly
specific labeling [6] of targeted tumors in examining [7]
and treating [8] tumors.n open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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in colorectal cancer [9], it is a useful indicator for treat-
ment progress according to the decreasing CEA level in
plasma [10]. Therefore, anti-CEA SPIONPs were devel-
oped as the contrast medium of MRI for colorectal can-
cer. However, because MRI requires a no-metal and
shielded environment, as well as the patient to lie inside
a coil, the procedure is limited to preoperative examin-
ation rather than intraoperative examination. Therefore,
the multimodality image contrast media of preoperative
and intraoperative examinations have emerged recently,
for example, nanoparticles used in preoperative MRI
with an additional near-infrared fluorescent [11] indica-
tor for intraoperative optical imaging or an additional
radioactive indicator for an intraoperative gamma im-
aging [12]. However, synthesizing various functional in-
dicators on nanoparticles increases not only the cost but
also the toxicity risk.
To accommodate the needs of preoperative and intra-
operative examinations using simple SPIONPs without
additional indicators, the superior magnetic characteristics
of SPIONPs should be examined for conducting different
in vivo examinations. For example, the paramagnetic or
superparamagnetic characteristics of SPIONPs have been
used for performing the image contrast of MRI [13]. Simi-
larly, the nonlinear response of SPIONPs was developed
to reveal SPIONP distributions by magnetic particle im-
aging (MPI). However, the field of view of MPI currently
is quite small, for example, the beating heart of a
mouse [14,15]. Recently, a scanning superconducting-
quantum-interference-device biosusceptometry (SSB)
system, possessing the advantage of an ultrasonic-like
operation, was developed to track SPIONPs noninva-
sively without using bioprobes in animals [16,17]. The
mechanism entails examining the in-phase component
of the AC susceptibility of SPIONPs.
In this work, to validate the simple anti-CEA-function-
alized SPIONPs demonstrating the ability to label colo-
rectal tumors, anti-CEA-functionalized SPIONPs were
synthesized and injected into mice implanted with colo-
rectal tumors for MRI and SSB examinations in vivo.
Methods
The Animal Care and Use Committee of National
Taiwan University approved all experimental protocols
(No. 20110009), named ‘Development of Core-technologies
and Applications of Nano-targeting Low-field Magnetic
Resonance Imaging.’ All experiments were conducted
according to the animal care guidelines of the university.
The used magnetic fluids (MFs), as shown in Figure 1a,
were composed of anti-CEA SPIONPs and water sol-
vents. Anti-CEA SPIONPs were synthesized from Fe3O4
SPIONPs without any antibody coating (MagQu Corp.,
Taipei, Taiwan). By oxidizing the dextran coating ofFe3O4 SPIONPs with NaIO4 to create aldehyde groups
(−CHO) [18], the dextran reacted with the anti-CEA
antibodies (10C-CR2014M5, Fitzgerald, Acton, MA,
USA) through -CH = N- to conjugate the anti-CEA anti-
bodies covalently. Performing magnetic separation then
separated the unbound antibodies from the MFs. The
used MFs were characterized according to magnetic
characteristics using a vibration sample magnetometer
(Model 4500, EG&G Corp., San Francisco, CA, USA),
according to particle size by dynamic laser scattering
(Nanotrac 150, Microtrac Corp., Montgomeryville, PA,
USA), and according to magnetic composition using a dif-
fractometer (D-500, Siemens Corp., Munich, Germany)
for powder X-ray diffraction.
For implanting the colorectal tumors, the injections of
the CT-26 cell line were processed through the skin on
the backs of 8-week-old mice. Three weeks later, 0.06
emu/g and 100 μl of anti-CEA SPIONPs in water were
injected into the tail veins of five mice. Two mice, mouse
1 and mouse 2, were examined using SSB and MRI mag-
netic instruments. The SSB examination schedule was at
the 0th, 14th, 26th, 40th, 68th, and 92nd hours for mouse
1 and at the 0th, 8th, 20th, and 42nd hours for mouse 2.
The MRI examination schedule was 4 h later than each
SSB examination time. Here, 0th represents the time be-
fore injection. Proving that the anti-CEA SPIONPs were
bound to the tumor tissue required determining the Fe
amount using inductively coupled plasma (ICP) and well-
known tissue staining methods, such as hematoxylin and
eosin (HE) staining, Prussian blue (PB) staining, anti-CEA
staining, and cluster of differentiation 31 (CD 31) staining,
to examine the tumor tissue of three mice, mouse 3,
mouse 4, and mouse 5, which were euthanized at the 0th,
24th, and 98th hours, respectively.
The SSB scheme, a novel magnetic handy probe as shown
in Figure 2a, has two major parts, the superconducting
quantum interference device (SQUID) unit and the scan-
ning probe unit. The SQUID unit was composed of a
high-Tc SQUID sensor (JSQ GmbH, Jülich, Germany)
surrounded by an input coil, cooled in liquid nitrogen, and
shielded in a set of shielding cans. The scanning probe
unit was composed of excitation and pickup coils, which
were moved by a three-axial step motor. The shielded
copper wires were connected to the pickup coils of the
scanning probe unit and the input coil of the SQUID unit
for flux transfer. Therefore, SSB has the superior advan-
tages of convenient magnetism measurement by moving
the scanning probe along any sample contour. Besides, the
measured signal intensity could be amplified by a suitable
transfer design. Both are opposite to the complex alignment
of the sample under a small SQUID sensor and have a sen-
sitivity limited by the mechanism of the cooing Dewar and
the shielding can for a general SQUID system. In addition
to the superior sensitivity of several picotesla, the excitation
Figure 1 Characterization of anti-CEA MFs. (a) The structural scheme of anti-CEA MFs. (b) Magnetization properties of anti-CEA MFs. (c) The
PXRD pattern of the crystalline SPIONPs. (d) Distribution of the hydrodynamic diameter of SPIONPs.
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animals because of their frequency-strength product being
smaller than the criteria of 4.85 × 108 kA/m s [19]. Under
the alternating-current (AC) magnetic excitation field, the
AC susceptibility of samples resulted in the AC magnetism
for SSB examination.
During the measurement process, the test mice were
initially anesthetized, and their back tumors were then
covered by a plastic plate with a tumor-fit hole to fix the
relative orientation and distance of the tumor from the
scanning probe unit. The scanning probe unit scanned the
entire tumors in several scanning paths with a vertical
interval of 0.1 mm. Thus, a magnetic image for the tumor
could be constructed, as shown in Figure 2a. SPIONPs
under AC field excitation generally expressed the charac-
teristics of AC susceptibility. Therefore, the SSB signal
from the in-phase component of the AC susceptibility
of SPIONPs was in proportion to the SPIONP concen-
tration [16].
The 3-T MRI (Bruker Biospec System, Karlsruhe,
Germany) and a volume coil were used for T2-weighted
images. In parallel with the arrangement of the anesthe-
tized mouse, a long tube filled with deionized (DI) waterwas inserted as the intensity reference to dismiss the in-
strument drift at various times. Producing the coronal
images of each entire mice body at 2-mm intervals re-
quired nearly 2 h.
In general, the uniformity of the static field and gradient
field is distorted by SPIONPs, resulting in the dephasing
of the proton nuclear spin and, subsequently, the reduc-
tion of nuclear magnetic resonance (NMR) intensity in-
duced by the pulse field of MRI [20]. Hence, the labeled
tumor cells using bound SPIONPs expressed a darker
image. Therefore, SPIONPs were the contrast agent of the
MR images.
For ICP examination (EVISA Instruments, PE-SCIEX
ELAN 6100 DRC, High Valued Instrument Center,
National Science Council, Kaohsiung, Taiwan), two pieces
of tumor tissue from one euthanized mouse were both
weighted by a 0.1-g weight and then dissolved entirely in a
HNO3 solution at a concentration of 65%; they were then
diluted and examined. To evaluate the incorporation of an
anti-CEA SPIONP quantity into the tumor tissue, the
difference of Fe concentration between the varied post-
injection and pre-injection times at the 0th hour was
expressed as ΔCFe (ppm).
Figure 2 SSB examination. (a) The schemes of SSB and its examination of a mouse with a colorectal tumor on its back. (b) The scanning curves
at maximum intensity.
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Center, National Taiwan University, Taipei, Taiwan), and
the × 400 magnification of the optical images was observed
using a light microscope. HE staining, PB staining, anti-
CEA staining, and CD 31 staining were performed to
identify the tumor tissue, Fe element distribution, and
anti-CEA SPIONP distribution; and the degree of tumor
angiogenesis was related to the transportation of anti-CEA
SPIONPs.
Results and discussion
Figure 1b shows the curve of the magnetism-applied field
(M-H) curve of anti-CEA SPIONPs. Based on the ultralow
hysteresis in the M-H curve, the anti-CEA SPIONPs
expressed superparamagnetic characteristics. Furthermore,
the X-ray pattern of the anti-CEA SPIONPs in Figure 1cdepicts the crystal structure of anti-CEA SPIONPs
obtained by X-ray diffraction. The major peaks correspond
with the standard X-ray pattern of Fe3O4 (JCPDS card no.
65–3107), verifying that the magnetic material was Fe3O4,
a magnetic iron oxide (IO). In addition, the distribution of
the hydrodynamic diameter, as shown in Figure 1d, indi-
cates that anti-CEA SPIONPs have a mean diameter of
50 ± 2 nm. In other words, anti-CEA SPIONPs belong to
the so-called ‘ultrasmall superparamagnetic iron oxides
(USPIOs)’ [21].
An entire colorectal tumor implanted in an anesthe-
tized mouse was scanned using the SSB scanning probe
for 4 min. After each scanning, a scanning curve was
obtained, as shown in the inset of Figure 2a. Among all
scanning curves at a time point, the scanning curve with
the largest Ipeak, the maximum intensity, was selected as
Figure 3 Comparison between ΔArea/Areamax by SSB and
Inormalized by MRI for mouse 1 and mouse 2.
Huang et al. Nanoscale Research Letters 2013, 8:413 Page 5 of 8
http://www.nanoscalereslett.com/content/8/1/413a representative for comparison with other Ipeak at vari-
ous times, as shown in Figure 2b. In Figure 2b, both
Ipeak and the peak width of the scanning curve increased
from the 0th hour, achieved the maximum at the 26th
hour for mouse 1 and the 20th hour for mouse 2, and
decreased to levels similar to those at the 0th hour.Figure 4 MRI examination. (a) MR images of mouse 1 and mouse 2 at va
image intensities of the entire and upper tumor regions. The figure inset sh
mouse 2, analyzed in the entire and upper tumor regions.Therefore, the reliable area of the scanning path, ‘Area,’
was used to analyze the magnetism of the entire tumors
by adding the products of the scanning step and the inten-
sities that were larger than the half of Ipeak. Here, the in-
tensities that were smaller than the half of Ipeak were
skipped because of the significant repeatability errors oc-
curring under particular experimental conditions such as
the arrangement of the mouse and mouse breath. Conse-
quently, the maximum Area of mouse 1 and mouse 2 oc-
curred separately at the 26th hour and the 20th hour. To
prove the reliability of the SSB results by comparing
them with the MRI results, the normalized parameter
ΔArea/Areamax was used to express the magnetic en-
hancement using anti-CEA SPIONPs on a colorectal
tumor, as shown in Figure 3. The examination of mag-
netic labeling of tumors by SSB, as shown in Figure 3, in-
dicated that the accumulation of anti-CEA SPIONPs
reached the highest level and gradually dissipated to the
initial level at approximately the 72nd hour. Because anti-
CEA SPIONPs showed not only the in-phase component
of the AC susceptibility for SSB examination but also the
superparamagnetic properties for MRI contrast imaging,
hence, the dynamic amount variation of anti-CEA
SPIONPs binding to colorectal tumors could be verified
by the Inormalized variation of the MR image with time.rious examination times. (b) The analytical comparison between the
ows the time variations of different image intensities of mouse 1 and
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colorectal tumors of mouse 1 and mouse 2 at various
times. Here, the entire tumor was marked with a blue out-
line and selected for analysis, and the DI water in the tube
was also used for comparison. Based on observation, the
tumor of mouse 2 became significantly dark at the 24th
hour and then recovered to brightness at the 0th hour. In
addition, the normalized intensity, Inormalized, was defined
as the ratio of the average intensity of the selected region
over that of DI water. The variation of Inormalized for the
entire tumor was analyzed, as shown in Figure 4b, indicat-
ing that Inormalized for the entire tumor around the first day
reached the minimum for mouse 2. However, for mouse 1
at the 18th and 30th hours, close to the first day, Inormalized
for the entire tumor had no significant difference from at
the 0th hour. These MRI results varied slightly from those
of the SSB examination. Therefore, the analyzed tumor in
the MR images was chosen as the upper region instead of
the entire tumor, as depicted in Figure 4b. Consequently,
the variation of Inormalized for both mouse 1 and mouse 2
generally reached the minimum at approximately the 24th
hour. Furthermore, ΔInormalized of the local upper region,
defined as the difference of Inormalized between post-
injection and the 0th hour, was used to evaluate the image
brightness variation of the parts of the tumors thatFigure 5 Biological results of the tumors of mouse 3, mouse 4, and m
anti-CEA staining, and CD 31 staining. (b) Iron amount by ICP. The circles aoccurred because of the accumulation of anti-CEA
SPIONPs, as depicted in Figure 4b. In comparison with
ΔArea/Areamax by SSB, Figure 3 shows that the magnetic
labeling of colorectal tumors using anti-CEA SPIONPs
could be examined by both SSB and MRI because of the
same variation trend of ΔArea/Areamax by SSB and
ΔInormalized by MRI at various times. The varied signs of
plus and negative properties were due to the distinct mag-
netic characteristics of anti-CEA SPIONPs and the en-
hancement of AC magnetic susceptibility [16] for SSB
different from the distortion of DC imaging field [20] for
MRI. In addition, regarding tumors implanted in the
mouse flank in other works, the similarity of this time-
varied trend [22] demonstrated the reasonability of using
specific probe-mediated SPIONPs in labeling tumors.
Furthermore, regarding the mentioned favorable agree-
ment between the SSB results and the MRI results of the
upper region of a labeled tumor rather than the entire re-
gion, it was explained as follows. In tumor development,
most of the scab tumors were possibly fiber tissue or dead
tumor cells in the tumor center; however, the upper re-
gion, in which more distribution of live tumor cells oc-
curred around the tumor center [23], constituted live cells
for binding anti-CEA coating SPIONPs. Hence, for colo-
rectal tumors labeled with developed anti-CEA SPIONPs,ouse 5. (a) Tissue staining methods of HE staining, PB staining,
re data points obtained from the measured results of two tissues.
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SSB was in charge of in vivo screening initially and
intraoperative positioning finally, and MRI worked for
only preoperative imaging.
Furthermore, these magnetic characteristics of a tumor
labeled with anti-CEA SPIONPs were verified using the
gold standard of biological assays, tumor tissue staining,
and ICP. Figure 5a shows the times at which the colorectal
tumors were removed from mouse 3 (at the 0th hour),
mouse 4 (at the 24th hour), and mouse 5 (at the 98th hour),
by PB staining, immunostaining of anti-CEA protein, CD
31 staining, and HE staining. As shown in the photo of HE
staining, these cells also developed in proximity to disorga-
nized architectures because of the increased ratio of nuclei
to cytoplasm. This indicated that these tissues were
obtained from tumors. Furthermore, there are significant
blue spots (arrows), representative of iron elements, in the
PB photo and brown spots (arrows) in the anti-CEA and
CD 31 photos at the 24th hour, but not at the 0th and 98th
hours. In addition, the distribution consistency of the blue
spots in the PB photos, as well as the brown spots in both
the anti-CEA and CD31 photos, indicated that the tumors
were labeled by these anti-CEA SPIONPs rather than
by biodegraded iron ions through the transportation of
microvessels. This also confirmed that selecting the upper
tumor region was more suitable than selecting the entire
tumor for MRI because of the live zone of the tumor with
both microvessels and anti-CEA SPIONPs.
Figure 5b shows the variation of the average iron
amounts in tumor tissues reaching the highest level at
the 24th hour and recovering at the 98th hour to the ini-
tial level at the 0th hour. Therefore, the various amounts
of both anti-CEA SPIONPs by tissue staining and Fe
element distribution by ICP correspond with the mag-
netic results obtained by SSB and MRI.
Conclusions
In summary, anti-CEA SPIONPs with simple structures
demonstrated superior magnetic characteristics for exam-
ining colorectal tumors in vivo. Because the dynamics of
magnetic labeling was consistent with biological phenom-
ena by tissue staining and ICP, the feasibility of examining
targeted colorectal tumors by SSB and MRI was proved.
This indicates that this type of anti-CEA SPIONP can be
used in a complete series of medical applications, such as
in vivo screening and intraoperative positioning, by SSB
and conducting preoperative examination by MRI.
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